Replies to post #105396 on Biotech Values

[jq1234]

Regeneron have a similar drug REGN475 (NGF antibody) in development. We'll see their data in the future to see whether similar effects occur in their patient population.

[DewDiligence]

This opens up a whole new avenue of excuses for biotech CEO’s whose products fail during clinical development :- )